AMPH
Amphastar Pharmaceuticals, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
26.93
close · 2026-10-29
value
89
cheaper than peers89
quality
46
stronger fundamentals46
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 6.52× | 83 |
| price to sales | 1.21× | 82 |
| price to book | 1.49× | 79 |
| forward P/E | 8.49× | 70 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 10.4% | 69 |
| operating margin | 8.0% | 54 |
| debt to equity | 88.7% | 44 |
| revenue growth | 0.4% | 34 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | $103.1M |
| employees | 1,976 |
| first trade | 2014-06-25 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 2.03 | 3.06 | 2.60 | 1.74 |
| free cash flow | $119.0M | $172.3M | $145.3M | $65.1M |
| net income | $98.1M | $159.5M | $137.5M | $91.4M |
| revenue | $719.9M | $732.0M | $644.4M | $499.0M |